Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01070888 · ClinicalTrials.gov registry record · Phase 4
Trial on the Effect of Budesonide/Formoterol and Inhaled Budesonide Alone on Exercise-Induced Asthma
A Phase 4 study, sponsored by Boston Children's Hospital.
- Terminated
- Registry status
- Phase 4
- Development phase
- 6
- Enrollment target
NCT01070888 is a Phase 4 study that was terminated before completion, run by Boston Children's Hospital. The registered enrollment target is 6 participants.
The verdict
NCT01070888, a Phase 4 study, was terminated before completion, sponsored by Boston Children's Hospital.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of this study is to find out if Symbicort® (budesonide/formoterol), a new combination asthma medication, is more effective than budesonide alone in controlling exercise induced asthma. The investigators hypothesize that in children and adults who suffer from asthma and exercise induced asthma there will be less decline in lung function associated with exercise when they receive the study medication.
Interventions
- DRUG Budesonide/Formoterol
- DRUG Budesonide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2010-02 |
| Est. Completion | 2014-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01070888
The ClinicalTrials.gov registry entry for NCT01070888 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Budesonide/Formoterol is the first listed.
NCT01070888 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01070888 about?
NCT01070888 is a clinical study titled "Trial on the Effect of Budesonide/Formoterol and Inhaled Budesonide Alone on Exercise-Induced Asthma". The purpose of this study is to find out if Symbicort® (budesonide/formoterol), a new combination asthma medication, is more effective than budesonide alone in controlling exercise induced asthma. The investigators hypothesize that in children and adults who suffer from asthma and exercise induced ...
What is the current status of trial NCT01070888?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 6 participants. The study started on 2010-02. Estimated completion is 2014-04.
What interventions are being tested in trial NCT01070888?
The interventions under investigation include: Budesonide/Formoterol (DRUG), Budesonide (DRUG).
Who is sponsoring clinical trial NCT01070888?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.